Site Search

... and will oppose proposals that create barriers to care for cancer patients, survivors, and those who could be diagnosed with cancer. Access to Biomarker Testing: ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...

... insurance can find themselves with medical debt. The problem for these patients is that their insurance may not cover medically appropriate testing and treatments. This forces many New Jerseyans to choose between their physical and financial health. For example, some health insurance plans may not cover the biomarker testing that a patient needs. This testing is a game-changer in the fight against cancer and an essential step in accessing precision ... looking to change that and increase access to this revolutionary testing by requiring state-regulated health plans, including Medicaid, to cover biomarker testing for patients who can benefit. “As we pursue the aforementioned opportunities to assist current patients, we must also consider ...

... Relations Director: “As Pennsylvania lawmakers return to the 2024 legislative session, ACS CAN calls on the Legislature to increase access to biomarker testing by voting in support of Senate Bill 954 / House Bill 1754. This legislation aims to equip countless Pennsylvanians who have received a ... diagnosis and their health care providers with critical information about their disease and how to best fight it.  “Despite the benefits of biomarker testing in improving patient outcomes and quality of life, health insurance coverage has not kept pace with innovations, coming up short ...

... toward their overall out-of-pocket maximum or deductible making cancer treatment more affordable.  Volunteers also asked the lawmakers to pass biomarker testing legislation (HB 608) that will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments. Dubbed ‘the right treatment, to the right patient, at the right ...